Both hemp and marijuana products are available in a variety of different forms, from oils and tinctures to edibles and chocolates. The main difference comes down to accessibility. Marijuana products are not legal in every state, and many states that do allow for medical marijuana require documentation or a card from your doctor. Usage also depends on what you want out of the product. You can’t use most forms of marijuana without getting high. Hemp products are mostly comprised of CBD with a fraction of a percent of THC (if any at all). This makes hemp oil more versatile for everyday use. Along with tinctures and oils, hemp is available in the form of capsules, edibles, chocolates, topical creams, lozenges, and more. Hemp oil is also great to cook with, and the wealth of products make measuring out and controlling serving sizes much easier. Hemp oil can also be used in vapes, but make sure you specifically get a hemp vape oil. A regular hemp oil or tincture, which is too thick to burn properly in a vape.

All CBD products start out the same way: as an extract from the leaves and flowers of cannabis plants. At Green Roads, we only extract CBD from hemp, defined as any variety of cannabis plant containing less than 0.3% THC by dry weight. Cannabinoids and terpenes are produced by tiny glands on the leaves and flowers of cannabis plants known as trichomes. The compounds produced by these trichomes give cannabis both its rich aroma and its nutraceutical effects.
A 2013 study conducted at the University of Haifa in Israel found that cannabinoid treatment after a traumatic experience may regulate the emotional response to the trauma and prevent stress-induced impairment. Cannabinoid treatment minimized the stress receptors in the basolateral amygdala (the nuclei that receives that majority of sensory information) and hippocampus (the part of the brain that is thought to be the center of emotion). (4)

Marijuana can produce acute psychotic episodes at high doses, and several studies have linked marijuana use to increased risk for chronic psychosis in individuals with specific genetic risk factors. Research suggests that these effects are mediated by THC, and it has been suggested that CBD may mitigate these effects.xxxi There have been a few small-scale clinical trials in which patients with psychotic symptoms were treated with CBD, including case reports of patients with schizophrenia that reported conflicting results; a small case study in patients with Parkinson’s disease with psychosis, which reported positive results; and one small randomized clinical trial reporting clinical improvement in patients with schizophrenia treated with CBD.xxxii Large randomized clinical trials would be needed to fully evaluate the therapeutic potential of CBD for patients with schizophrenia and other forms of psychosis.